AJP - Lung Cellular and Molecular Physiology, Vol 269, Issue 4 443-L452, Copyright © 1995 by American Physiological Society

ARTICLES

Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages

N. Berkman, P. J. Jose, T. J. Williams, T. J. Schall, P. J. Barnes and K. F. Chung
Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.

One of the major inducible cytokines secreted by mononuclear phagocytes is macrophage inflammatory protein 1 (MIP-1), which consists of two homologous polypeptides, MIP-1 alpha and MIP-1 beta. MIP-1 alpha possesses chemotactic and stimulatory activities for lymphocytes, eosinophils, and monocytes and may play a role in various pulmonary inflammatory conditions. We investigated the expression and release of MIP-1 alpha from human peripheral blood monocytes (PBM) and alveolar macrophages (AM) after stimulation with lipopolysaccharide (LPS), interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha, and interferon-gamma and the inhibitory effects of corticosteroids. LPS and IL-1 beta only enhanced MIP-1 alpha mRNA and protein in a dose- and time-dependent fashion. Dexamethasone (10(-9) to 10(-4) M) inhibited the basal and induced production and expression of MIP-1 alpha. In PBM, dexamethasone (10(-6) M) reduced LPS- and IL-1 beta-stimulated production of MIP-1 alpha protein by 50 and 63%, respectively, maximally at 24 h, whereas the inhibition of mRNA expression occurred maximally at 4 h. Similar trends were observed for AM. MIP-1 alpha mRNA decay was only slightly decreased in the presence of dexamethasone. Inhibition of LPS-induced MIP-1 alpha mRNA by dexamethasone was attenuated by the protein synthesis inhibitor cycloheximide, indicating the involvement of a protein intermediate. Corticosteroids are a potent inhibitor of IL-1 beta- and LPS-induced expression of MIP-1 alpha through mechanisms involving mainly inhibition of transcription and to a minor degree by reducing mRNA stability. Corticosteroids may be effective anti-inflammatory agents by preventing the expression of chemokines such as MIP-1 alpha.

This article has been cited by other articles:

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				L. Piemonti, P. Monti, P. Allavena, M. Sironi, L. Soldini, B. E. Leone, C. Socci, and V. Di Carlo Glucocorticoids Affect Human Dendritic Cell Differentiation and Maturation J. Immunol., June 1, 1999; 162(11): 6473 - 6481. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				V. Kodelja, C. Muller, O. Politz, N. Hakij, C. E. Orfanos, and S. Goerdt Alternative Macrophage Activation-Associated CC-Chemokine-1, a Novel Structural Homologue of Macrophage Inflammatory Protein-1{alpha} with a Th2-Associated Expression Pattern J. Immunol., February 1, 1998; 160(3): 1411 - 1418. [Abstract] [Full Text] [PDF]

				C. M. McManus, C. F. Brosnan, and J. W. Berman Cytokine Induction of MIP-1{alpha} and MIP-1{beta} in Human Fetal Microglia J. Immunol., February 1, 1998; 160(3): 1449 - 1455. [Abstract] [Full Text] [PDF]

				M. JOHN, S. LIM, J. SEYBOLD, P. JOSE, A. ROBICHAUD, B. O'CONNOR, P. J. BARNES, and K. FAN CHUNG Inhaled Corticosteroids Increase Interleukin-10 but Reduce Macrophage Inflammatory Protein-1alpha , Granulocyte-Macrophage Colony-stimulating Factor, and Interferon-gamma Release from Alveolar Macrophages in Asthma Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 256 - 262. [Abstract] [Full Text]